You can find the annual or quarterly income statement of LB Pharmaceuticals Inc here for insights into the performance and operational efficiency of LB Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

Operating expenses

--13.87M

--5.25M

R&D expenses

--8.48M

--2.42M

Depreciation, depletion, and amortization

----

--81.00K

Operating profit

----

---5.25M

Net non-operating interest income (expenses)

Non-operating interest income

--2.80M

--707.00K

Gains from sale of securities

--0.00

Special income (expenses)

---401.00K

--983.00K

Income before tax

---11.47M

---3.56M

Income tax

--1.00K

--0.00

Income after tax

---11.47M

---3.56M

Net income from continuous operations

---11.47M

---3.56M

Net income attributable to controlling interests

---11.47M

---3.56M

Net income attributable to common shareholders

---11.47M

---3.56M

Basic earnings per share

----

---0.14

Diluted earnings per share

----

---0.14

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

